- Home
- MHF vs SGMO Comparison
MHF vs SGMO Comparison
Compare MHF & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MHF | SGMO |
|---|---|---|
| Founded | 1988 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 141.2M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | MHF | SGMO |
|---|---|---|
| Price | $6.87 | $0.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 53.5K | ★ 3.6M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,567,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $6.61 | $0.35 |
| 52 Week High | $7.83 | $1.04 |
Technical Indicators
Market Signals| Indicator | MHF | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 44.64 |
| Support Level | $6.85 | $0.36 |
| Resistance Level | $7.02 | $0.56 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 11.11 | 7.06 |
Price Performance
Historical ComparisonAbout MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.